Spirometer is an apparatus that measures
the capacity of lungs. It is used to perform pulmonary function tests
(PFT). The device specifically measures volume and speed (flow) of air
inhaled and exhaled by lungs during breathing. Spirometers are helpful
in assessing respiratory disorders such as asthma, emphysema, and
bronchitis by inspecting ventilation i.e., obstructive and restrictive
patterns of a lung. The airflow is measured by ultrasonic waves and
Doppler effect technology. Recent advancements in sensor technology for
ultrasonic spirometers enable the device to be optimized for home
monitoring. Ultrasonic flow metering allows the manufacture of
easy-to-use and low-maintenance spirometers.
Increase in preference for home-based diagnostic tools, efficient
monitoring of pulmonary functions by ultrasound spirometers, and rise in
prevalence of respiratory diseases such as asthma across the globe are
likely to fuel the growth of the global ultrasonic spirometers market
during the forecast period. However, lack of awareness about
technological advancements in spirometers in developing countries and
reimbursement issues for ultrasonic spirometers in some countries are
projected to restrain the global ultrasonic spirometers market from 2018
to 2026.
The global ultrasound spirometers market can be segmented based on
technology and end-user. In terms of technology, the global market can
be classified into volume measurement, peak flow measurement, and flow
measurement. The peak flow meters segment dominated the market in 2017
due to rise in prevalence of chronic obstructive pulmonary disorders
(COPD) and aging global population. The segment is expected to continue
to lead the market during the forecast period, owing to automatic
internal calibration of ultrasonic spirometers and introduction of
ultraviolet (UV) light assisted disinfection feature in the device by
key manufacturers. However, rise in number of smokers across the globe
and government participation in prevention & control of respiratory
disorders are expected to propel the flow measurement segment from 2018
to 2026. In terms of end-user, the global ultrasonic spirometers market
can be categorized into hospitals, clinics, home care settings, and
others. The hospitals segment accounted for the largest market share in
terms of revenue in 2017, attributed to rise in investment by public
& private players for the betterment of healthcare sector in the
developing countries, and favorable reimbursement policies. However,
ultrasonic spirometers do not require daily external calibration, which
is likely to propel usage in clinics and home care settings. Rise in
number of patients with asthma and bronchitis owing to increasing air
pollution is projected to boost the growth of the home care settings
segment from 2018 to 2026.
Geographically, the global ultrasonic
spirometers market can be segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. North America
accounted for the largest market share in 2017, attributed to increase
in strategic operations of key manufacturers in the U.S. and Canada and
rise in per capita expenditure of the population on health care.
Emergence of local & regional manufacturers for ultrasonic
spirometers in Europe is expected to augment the market in the region
during the forecast period. However, Asia Pacific is projected to be the
fastest growing market for ultrasound spirometers from 2018 to 2026,
due to rise in adoption of digital connectivity in diagnostic equipment,
cost-efficient design of ultrasonic spirometers, and efficient
integration in hospital information systems.
Key players operating in the global ultrasonic spirometers market
include Vitality Medical, ndd Medizintechnik AG, KWIPPED, Inc., Henry
Schein, Inc., Meditech Equipment Co., Ltd., Schiller AG, Welch Allyn, GE
Healthcare, Uscom Ltd., Contec Medical Systems Co., Ltd., and Midmark
Corp. Introduction of advanced features such as wireless connectivity in
ultrasonic spirometers is a key focus of the manufacturers to stay
ahead of the competition.
No comments:
Post a Comment